Comparative Analysis of miRNA Expression Profiles of Multiple Myeloma with 1q21 Gains and Normal FISH

被引:3
作者
Cui, Yushan [1 ]
Liu, Yang [1 ]
Wang, Danyang [1 ]
Liu, Yuzhang [1 ]
Liu, Lina [1 ]
Fang, Baijun [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China
关键词
Multiple myeloma; Micro RNA; 1q21; Fluorescence in situ hybridisation; MICRORNA EXPRESSION; RISK STRATIFICATION; FAMILY; PROGRESSION; PREDICTION; CANCER; CELLS; 2A;
D O I
10.1159/000486662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple myeloma (MM) with 1q21 gains invariably has a poor prognosis. Many recent studies have reported the relationship between micro (mi) RNA expression and MM prognosis. However, there is little information on the association between miRNA alterations and 1q21 gains. Methods: We compared the miRNA expression profiles of MM with 1q21 gains and MM with normal fluorescence in situ hybridisation (FISH) by gene expression array. Differentially expressed miRNAs were identified using Affymetrix TAC software. Thresholds were defined as a false discovery rate <0.05, p value <0.05, and n-fold change >2. Results: Six miRNAs (let-7f-5p and -7g-5p, and miR-29a-3p,-29b-1-5p, -331-3p, and-223-3p) were downregulated and 4 (miR-30e-5p, -17-3p,-18b-5p, and-19a-3p) were upregulated in MM with 1q21 gains relative to MM with normal FISH. Conclusions: The identified set of miRNAs can serve as biomarkers for distinguishing MM with 1q21 gains from MM with normal FISH. (C) 2018 S. Karger AG, Basel.
引用
收藏
页码:96 / 100
页数:5
相关论文
共 27 条
  • [1] Role of micro-RNAs in drug resistance of multiple myeloma
    Abdi, Jahangir
    Jian, Hou
    Chang, Hong
    [J]. ONCOTARGET, 2016, 7 (37) : 60723 - 60735
  • [2] Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
    Bergsagel, P. Leif
    Mateos, Maria-Victoria
    Gutierrez, Norma C.
    Rajkumar, S. Vincent
    Miguel, Jesus F. San
    [J]. BLOOD, 2013, 121 (06) : 884 - 892
  • [3] MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy
    Bong, Ivyna Pau Ni
    Ng, Ching Ching
    Baharuddin, Puteri
    Zakaria, Zubaidah
    [J]. GENES & GENOMICS, 2017, 39 (05) : 533 - 540
  • [4] Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
    Feng, Dan-Dan
    Zhang, Hua
    Zhang, Peng
    Zheng, Yu-Sheng
    Zhang, Xing-Ju
    Han, Bo-Wei
    Luo, Xue-Qun
    Xu, Ling
    Zhou, Hui
    Qu, Liang-Hu
    Chen, Yue-Qin
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (10) : 2164 - 2175
  • [5] DNA methylation changes in multiple myeloma
    Galm, O
    Wilop, S
    Reichelt, J
    Jost, E
    Gehbauer, G
    Herman, JG
    Osieka, R
    [J]. LEUKEMIA, 2004, 18 (10) : 1687 - 1692
  • [6] Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
    Gutierrez, N. C.
    Sarasquete, M. E.
    Misiewicz-Krzeminska, I.
    Delgado, M.
    De Las Rivas, J.
    Ticona, F. V.
    Ferminan, E.
    Martin-Jimenez, P.
    Chillon, C.
    Risueno, A.
    Hernandez, J. M.
    Garcia-Sanz, R.
    Gonzalez, M.
    San Miguel, J. F.
    [J]. LEUKEMIA, 2010, 24 (03) : 629 - 637
  • [7] Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells
    Kang, HS
    Lee, BS
    Yang, Y
    Park, CW
    Ha, HJ
    Pyun, KH
    Choi, I
    [J]. CELLULAR IMMUNOLOGY, 1996, 168 (02) : 174 - 183
  • [8] Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
    Kapoor, Prashant
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Sinha, Shirshendu
    Gertz, Morie A.
    Stewart, A. Keith
    Bergsagel, P. Leif
    Lacy, Martha Q.
    Dingli, David D.
    Ketterling, Rhett P.
    Buadi, Francis
    Kyle, Robert A.
    Witzig, Thomas E.
    Greipp, Philip R.
    Dispenzieri, Angela
    Kumar, Shaji
    [J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 532 - 537
  • [9] The role of miR-29 family members in malignant hematopoiesis
    Kollinerova, Sona
    Vassanelli, Stefano
    Modriansky, Martin
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (04): : 489 - 501
  • [10] MicroRNAs in the Pathobiology of Multiple Myeloma
    Lionetti, Marta
    Agnelli, Luca
    Lombardi, Luigia
    Tassone, Pierfrancesco
    Neri, Antonino
    [J]. CURRENT CANCER DRUG TARGETS, 2012, 12 (07) : 823 - 837